Protai ^Company

Protai is an organization that focuses on driving drug discovery and development through the use of proteomics and artificial intelligence (AI). They aim to comprehensively map the course of diseases on the protein level, allowing for a better understanding of cellular function and the development of new drugs. Protai's deep map of protein networks enables them to precisely target complex disease drivers and influence the course of disease. They leverage proteomics data and other protein-oriented large-scale datasets, using machine learning to accurately simulate disease on the molecular level. Protai has developed a proteomics-centered platform that covers the entire drug discovery process, from data collection to target identification and drug development, providing novel insights into the mechanisms of action.